These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Analysis of loss-of-function variants and 20 risk factor phenotypes in 8,554 individuals identifies loci influencing chronic disease. Li AH; Morrison AC; Kovar C; Cupples LA; Brody JA; Polfus LM; Yu B; Metcalf G; Muzny D; Veeraraghavan N; Liu X; Lumley T; Mosley TH; Gibbs RA; Boerwinkle E Nat Genet; 2015 Jun; 47(6):640-2. PubMed ID: 25915599 [TBL] [Abstract][Full Text] [Related]
24. Biomarkers for type 2 diabetes. Laakso M Mol Metab; 2019 Sep; 27S(Suppl):S139-S146. PubMed ID: 31500825 [TBL] [Abstract][Full Text] [Related]
25. DNA Methylation and MicroRNA-Based Biomarkers for Risk of Type 2 Diabetes. O'Connell TM; Markunas CA Curr Diabetes Rev; 2016; 12(1):20-9. PubMed ID: 25981498 [TBL] [Abstract][Full Text] [Related]
26. Assessing the causal association of glycine with risk of cardio-metabolic diseases. Wittemans LBL; Lotta LA; Oliver-Williams C; Stewart ID; Surendran P; Karthikeyan S; Day FR; Koulman A; Imamura F; Zeng L; Erdmann J; Schunkert H; Khaw KT; Griffin JL; Forouhi NG; Scott RA; Wood AM; Burgess S; Howson JMM; Danesh J; Wareham NJ; Butterworth AS; Langenberg C Nat Commun; 2019 Mar; 10(1):1060. PubMed ID: 30837465 [TBL] [Abstract][Full Text] [Related]
27. The genetics of type 2 diabetes and its clinical relevance. Pal A; McCarthy MI Clin Genet; 2013 Apr; 83(4):297-306. PubMed ID: 23167659 [TBL] [Abstract][Full Text] [Related]
32. Association analysis of 29,956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion. Yaghootkar H; Stancáková A; Freathy RM; Vangipurapu J; Weedon MN; Xie W; Wood AR; Ferrannini E; Mari A; Ring SM; Lawlor DA; Davey Smith G; Jørgensen T; Hansen T; Pedersen O; Steinthorsdottir V; Guðbjartsson DF; Thorleifsson G; Thorsteinsdottir U; Stefansson K; Hattersley AT; Walker M; Morris AD; McCarthy MI; Palmer CN; Laakso M; Frayling TM Diabetes; 2015 Jun; 64(6):2279-85. PubMed ID: 25605810 [TBL] [Abstract][Full Text] [Related]
33. Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies. Zhu H; Leung SW Diabetologia; 2015 May; 58(5):900-11. PubMed ID: 25677225 [TBL] [Abstract][Full Text] [Related]
34. Rare and common genetic events in type 2 diabetes: what should biologists know? Bonnefond A; Froguel P Cell Metab; 2015 Mar; 21(3):357-68. PubMed ID: 25640731 [TBL] [Abstract][Full Text] [Related]
36. A cautionary tale: the non-causal association between type 2 diabetes risk SNP, rs7756992, and levels of non-coding RNA, CDKAL1-v1. Locke JM; Wei FY; Tomizawa K; Weedon MN; Harries LW Diabetologia; 2015 Apr; 58(4):745-8. PubMed ID: 25634229 [TBL] [Abstract][Full Text] [Related]
37. Gene-environment interaction between adiponectin gene polymorphisms and environmental factors on the risk of diabetic retinopathy. Li Y; Wu QH; Jiao ML; Fan XH; Hu Q; Hao YH; Liu RH; Zhang W; Cui Y; Han LY J Diabetes Investig; 2015 Jan; 6(1):56-66. PubMed ID: 25621134 [TBL] [Abstract][Full Text] [Related]
38. Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes. Kelsey MM; Bjornstad P; McFann K; Nadeau K Pediatr Diabetes; 2016 May; 17(3):184-90. PubMed ID: 25611822 [TBL] [Abstract][Full Text] [Related]
39. The VGF-Derived Neuropeptide TLQP-21 Shows No Impact on Hormone Secretion in the Isolated Perfused Rat Pancreas. Christiansen CB; Svendsen B; Holst JJ Horm Metab Res; 2015 Jun; 47(7):537-43. PubMed ID: 25602348 [TBL] [Abstract][Full Text] [Related]